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The influence of Satureja montana extracts on several liver biochemical parameters in mice admin-
istered with carbon tetrachloride was estimated. In vivo investigation of antioxidant properties
of S. montana extracts encompassed monitoring of biochemical parameters (derived from liver ho-
mogenate and blood hydrolyzate) and examination of potential hepatoprotective effect after intoxi-
cation with carbon tetrachloride. Biochemical tests included determination of activity of several an-
tioxidant enzymes: xanthine oxidase, catalase, peroxidase, glutathione peroxidase, amount of reduced
glutathione and intensity of lipid peroxidation. In order to obtain data about the potent hepatopro-
tective effect of examined extracts, the following parameters were determined: aspartate aminotrans-
ferase, alanine aminotransferase, bilirubin, hepatic DNA and hydroxyprolin. Results of this study
demonstrate that S. montana extracts inhibited the hepatotoxicity produced by carbon tetrachloride
administration most probably through activation of physiological common defense mechanisms.
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1. INTRODUCTION
Winter savory (Satureja montana L.) grows widely in the Balkan
region and belongs to a very important family of medici-
nal plants, the Lamiaceae family. Winter savory is an aro-
matic herb which is traditionally used as a spice and natural
food preservative and represents a common ingredient in folk
medicines for therapy of different digestive, respiratory, and
urinary ailments. Furthermore, it is quite often used as a tonic
for strengthening the immune system. In addition, our previ-
ous results showed that it could be recommended for skin and
mucous membrane inflammation (Vladic´ et al., 2017a). Apart
from this, frequent use in traditional medicine and overall in-
crease of interest in natural remedies has also been a basis for
scientific research conducted for the purposes of confirming S.
montana’s biological activities. Significant antioxidative poten-
tial of S. montana was confirmed for essential oil, extracts ob-
tained by conventional extraction methods, as well as extracts
obtained by modern extraction methods (C´avar et al., 2008;
2014; Grosso et al., 2009; Serrano et al., 2011; Vidovic´ et al., 2014;
Vladic´ et al., 2017b). In addition to its antioxidative activity,
winter savory possesses antimicrobial, diuretic, antiprolifer-
ative, angiotensin-converting enzyme (ACE) inhibitory, and
anti-HIV-1 activity (C´avar et al., 2014; Cetojevic´-Simin et al.,
2004; Prieto et al., 2007; Serrano et al., 2011; Skocˇibušic´ and
Bezic´, 2004; Stanic and Samaržija, 1993; Vidovic´ et al., 2014;
Vladic´ et al., 2017a; 2016; Yamasaki et al., 1998).
Winter savory is a herb rich in carvacrol, a representative of
oxidative monoterpenes which exhibits significant antioxi-
dant potential, both in vitro and in vivo (Aeschbach et al., 1994;
Aristatile et al., 2015; 2009; Guimarães et al., 2010; Slamenova
et al., 2011). Also, it was confirmed that carvacrol demon-
strated characteristics of a hepatoprotective agent in in vivo
models (Aeschbach et al., 1994; Aristatile et al., 2009; Suntres
et al., 2015). The hepatoprotective effect of carvacrol had been
correlated with its capacity to preserve the integrity of hepato-
cellular membrane and oxidant/antioxidant balance in liver
(Aristatile et al., 2009). In addition, studies were conducted
where the hepatoprotective effect of species which belong to
the genus Satureja (S. macrostema and S. khuzestanica) (Assaei
et al., 2014; Gutierrez and Navarro, 2010). Based on the impor-
tance and role of carvacrol, as well as the antioxidant effect of
S. montana, and confirmed beneficial activity of some species
from genus Satureja, the starting point of our study was to
evaluate pharmacological potency of S. montana extracts. In
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our previous study, green extraction method, supercritical
carbon dioxide extraction (SC-CO2), was established for ob-
taining S. montana extracts (Vidovic´ et al., 2014). In that study,
process parameters of SC-CO2 were determined with the aim
to produce S. montana extract with the highest concentration of
carvacrol. Considering the fact that carbon dioxide is a solvent
with an affinity for non-polar compounds, in the other study
water/ethanol mixture was chosen as a solvent because of its
affinity for polar compounds. Liquid ethanol-water extract
was then converted into dry form via spray drying technology
(Vladic´ et al., 2016). Selected extracts of S. montana obtained in
previously mentioned studies were selected for investigation
in this study (Vidovic´ et al., 2014; Vladic´ et al., 2016).
Therefore, the main aim of this study was to assess the hepato-
protective potential of S. montana extracts in a mouse model
of carbon tetrachloride (CCl4) induced liver toxicity.
2. MATERIALS AND METHODS
2.1. Plant material
Aerial parts of winter savory (Satureja montana) was collected
at the Institute of Field and Vegetable Crops, Bacˇki Petrovac,
Republic of Serbia, in July 2012. Collected plant material has
been naturally dried and then stored in paper bags at the room
temperature.
2.2. Chemicals
Carbon tetrachloride (>99.5%) was purchased from Kemika
(Croatia) and methanol (>99.9%) were purchased from Sigma-
Aldrich (Germany). All other chemicals were of analytical
reagent grade.
2.3. Preparation of extracts
The detailed procedure of obtaining S. montana extract (SME1)
by SC-CO2 extraction had been described by (Vladic´ et al.,
2016). Briefly, the extraction of S. montana herbal material was
conducted using supercritical carbon dioxide at a pressure of
350 bar and temperature of 50 °C. The extraction time was 4.5
hours. The separator conditions were 15 bar and 23 °C (Vladic´
et al., 2016).
The detailed procedure of obtaining S. montana extract via
spray drying is described by Vidovic´ et al. (2014). Spray-dried
extract (SME2) is produced by the drying of liquid extract
via spray drying technology (inlet temperature 120 °C, outlet
temperature 80 °C). S. montana liquid extract was obtained
using 50% ethanol/water mixture as an extraction solvent.
Extraction was carried out for five days at room temperature
in a dark place. Maltodextrin (DE16) in the percentage of
10% (calculated on extract dry weight) was used as a carrier
material (Vidovic´ et al., 2014).
2.4. Animals and treatments
Animal care and all experimental procedures were conducted
in accordance with the Guide for the Care and Use of Labora-
tory Animal Resources edited by the Commission of Life Sci-
ences, National Research Council. All procedures performed
in studies involving animals were in accordance with the ethi-
cal standards of the institution (University of Novi Sad; EK:
II-2013-03; 01-160-5). Animals were fed with standard mouse
chow (LM2, Veterinarski zavod, Subotica, Serbia) had free
access to tap water at a temperature of 25 °C and controlled
humidity (30-50%), in the animal house under 12 h light/day
cycles. SME1 was dissolved in olive oil in a concentration
of 1%. The SME2 was dissolved under sonication in water
(1%; w/v) and filtered through 0.45 mm membrane filter. The
resulting solutions were kept refrigerated at a temperature of
4 °C. The extracts were administered intraperitoneally (i.p.).
The variability in the volume of administered doses was man-
aged by adjusting the concentration to ensure a constant vol-
ume (2 mL/kg body weight). The carbon tetrachloride (CCl4)
was also administered intraperitoneally (2 mL/kg) 24 h be-
fore sacrifice. The animals were randomly allocated to six
groups of six in each group, under the following conditions
and treatments: control group: – the mice received 1 mL/kg
(i.p.) distilled water for 7 days; control + CCl4: the mice were
treated with 1 mL/kg (i.p.) distilled water for 7 days and 2
mL/kg (i.p.) of CCl4 (day 7) 24 hours before sacrifice; SME1,
SME2: the mice were treated with the investigated S. montana
extracts (SME1 and SME2), receiving 2 mL/kg (i.p.) for 7 days;
SME1 + CCl4, SME2 + CCl4 – the mice were treated with the
same dosage of extracts, followed by 2 mL/kg (i.p.) of CCl4
(day 7) 24 h before sacrifice.
At the end of the experiment (day 8), the animals were anes-
thetized with isofluorane, decapitated and exsanguinated. Liv-
ers were excised immediately after the animals were sacrificed.
Liver homogenates were prepared in the following way: 1 g
of liver tissues were homogenized with Tris–HCl: saccharose
solution (50 mmol/L; 0.25 mol/L; pH 7.40), 1:3, 4 °C, using
a glass Potter-Elvehjem homogenizer set. The resulting ho-
mogenate was centrifuged at 3000 rpm for 10 min, and the
concetration of proteins was determined by biuretic method
using bovine serum albumine as a standard (Wood, 2012).
Samples of blood and liver were used for determination of
biochemical parameters of oxidative stress.
2.5. Biochemical assays
The activity of xanthine oxidase (XOD) was determined using
the Lück (1965) method, catalase (CAT) according to Beers and
Sizer (1952), peroxidase (Px) according to Simon et al. (1974)
glutathione peroxidase (GSH-Px) according to Beutler et al.
(1963) and glutathione reductase (GR) according to Goldberg
and Spooner (1983). Amount of reduced glutathione (GSH)
was also determined Beutler (1984), as well as the intensity
of lipid peroxidation (LPx) using the Buege and Aust (1978)
protocol. The content of hepatic DNA was determined ac-
cording to Schulte-Hermann et al. (1988). Contents of serum
aspartate aminotransferase (AST), alanine aminotransferase
(ALT) and bilirubin were determined following the Reitman
and Wootton method. The concentration of hydroxyproline
was also determined using Woessner (1961) protocol. All the
measurements were performed in triplicate.
2.6. Statistical analysis
The activities are expressed as mean ± standard deviation.
Mean values between the groups in biochemical analyses
were considered significantly different at the p<0.05 confi-
dence level, after performing a one-way single factor ANOVA,
followed by Tukey and Bonferroni multiple comparison post
hoc tests.
3. RESULTS AND DISCUSSION
Different agents can be responsible for liver damage and dis-
ease, including viruses, hepatotoxic chemicals, as well as pol-
lution. The hepatotoxicity produced by CCl4 administration
is frequently used as a model for examination of the liver (C´e-
bovic´ and Maksimovic´, 2012; Manna et al., 2006; Gutierrez and
Navarro, 2010; Sreelatha et al., 2009; Yang et al., 2010). The ef-
ficacy of any hepatoprotective agent depends on its capability
to reduce effects of CCl4 or to maintain normal physiological
function, which was disrupted due to hepatotoxin application.
The results of an investigation of S. montana extracts’ influ-
ence on parameters of oxidative stress induced by CCl4 are
presented in Table 1. Several activities were analyzed, such as
xanthine oxidase (XOD), catalase (CAT), peroxidase (Px), glu-
tathione reductase (GR) and glutathione peroxidase (GSHPx),
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Table 1. Effects of SC-CO2 (SME1) and spray-dried (SME2) extracts of winter savory (S. montana) on oxidative stress biochemical parameters.
Group Biochemical parameters
XODa CAT Px GR GSH-Px GSH LPx
Control 1.93 ± 0.02 9.56 ± 0.37 10.68 ± 1.38 6.13 ± 0.07 8.70 ± 0.38 4.98 ± 0.16 3.04 ± 0.07
Control+CCl4 1.89 ± 0.02 3.32 ± 0.05 a 4.87 ± 0.28 a 1.2 ± 0.10 a 21.75 ± 1.35 a 0.57 ± 0.28 a 9.79 ± 1.46 a
SME1 1.87 ± 0.03 a 13.4 ± 0.59 a,b 14.88 ± 0.38 a,b 7.03 ± 0.46 b 7.54 ± 2.23 b 4.99 ± 0.17 b 2.62 ± 0.54 b
SME1+CCl4 1.93 ± 0.01 9.02 ± 0.16 b 9.52 ± 1.15 b 5.84 ± 2.11 b 10.94 ± 1.73 b 3.34 ± 0.75 a,b 3.97 ± 0.11 b
SME2 1.86 ± 0.03 a 12.37 ± 0.18 a,b 14.57 ± 0.80 a,b 6.53 ± 1.61 b 6.67 ± 1.06 b 4.92 ± 0.39 b 2.21 ± 0.24 b
SME2+CCl4 1.92 ± 0.03 8.72 ± 0.29 a,b 9.30 ± 0.72 b 5.41 ± 0.40 b 12.42 ± 0.64 a,b 2.9 ± 0.73 a,b 3.94 ± 0.98 b
a Values are expressed as mean ± standard deviation of six mice. Activities of xanthine oxidase (XOD), catalase (CAT), peroxidase (Px), glutathione reductase (GR) and
glutathione peroxidase (GSHPx) are expressed in nmol/mg of protein min-1. Content of hepatic reduced glutathione (GSH) is expressed in nmolGSH/mg of protein. Intensity
of lipid peroxidation (LPx) is expressed in nmol/MDA/mg of protein; MDA, malonyldialdehyde. Letters a and b denote statistically significant difference from the Control
group and from the Control+CCl4 group based on post-hoc Bonferroni test at P<0.05 level.
along with glutathione content (GSH) and intensity of lipid
peroxidation (LPx). Evaluation of the hepatoprotective influ-
ence of S. montana extracts on mice with chemically induced
toxicity is expressed by measurement of hepatic DNA content,
hydroxyproline, and bilirubin, as well as activities of serum
parameters AST and ALT, before and after CCl4 intoxication
(Table 2).
Regarding XOD activity, no change was noticed after CCl4
administration nor upon administration of extracts+CCl4
(SM1+CCl4 and SM2+CCl4). The observation that CCl4 admin-
istration did not influence strongly XOD activity was reported
previously in the literature (C´ebovic´ and Maksimovic´, 2012).
CAT represents one of the most efficient enzymes and its key
role is to dissolve hydrogen peroxide to water and oxygen, in
that way performing cell protection from oxidative damage
induced by hydrogen peroxide (Blokhina, 2003). Intraperi-
toneal CCl4 administration led to a significant reduction of
CAT activity (2.9-fold) in comparison to untreated control
group, while pretreatment with extracts led to a significant
reduction of CCl4 influence and an increase of enzymatic activ-
ity to a value close to the control group. Investigated extracts
(SME1 and SME2) increased Px activity in comparison to the
control group, while CCl4 administration reduced its activity
almost 2-fold. Similar as in the case of CAT, pretreatment with
extracts led to a decrease of hepatotoxic CCl4 effect, i.e. en-
zymatic activity maintained close to Px activity measured in
the untreated control group, which can be an indicator of in-
creased production of hydrogen peroxide, partially converted
into the water via both CAT and Px.
Administration of CCl4 led to a crucial drop in GSH levels,
which indicates that significant damage of hepatocyte ap-
peared. The application of extracts with CCl4 significantly
increased the amount of GSH (by comparison with the nega-
tive control group), but significantly lower than the value of
the untreated group, i.e. they failed to completely eliminate
the negative CCl4 effect.
Significant differences in the effects of applied extracts, which
succeeded to suppress CCl4 influence, were not found. It is a
statistically important observation having in mind the multi-
ple decreases of enzymatic activity via CCl4 administration.
Regarding the function of GR to maintain a high level of GSH
activity, it can be concluded that reductions of activities of both
GSH and GR after CCl4 application, were correlated. There-
fore, extracts’ influences exerted on GR and GSH activities
indicate a protective effect of extracts.
GSHPx is responsible for cell protection from the harmful
effect of endogenously formed hydroperoxide through degra-
dation into water and oxygen, and can also be responsible for
detoxification of lipid peroxide generated by reactive oxygen
species (Blokhina, 2003). CCl4 administration led to a signifi-
cant increase of enzymatic activity, while it was significantly
decreased (compared to the negative control group) in the
groups treated with extracts. Application of SME1 led to a de-
crease of enzymatic activity up to a basal value of the control
group. Therefore, extracts succeeded in suppressing the toxic
effects of excessive production of free radicals caused by CCl4
application.
CCl4 application led to a significant increase in intensity of
lipid peroxidation. Pretreatment with extracts, managed to
prevent oxidative damage, caused by CCl4, without a differ-
ence in activity. Pretreatment with extracts can potentially
prevent loss of integrity of the hepatocellular membrane be-
cause of their capability to inhibit lipid peroxidation and in
that way protect lipid membranes from oxidative damage.
Hence, it is possible to evaluate their antioxidant potential, as
well as hepatoprotective, by inducing damage of hepatocyte
membrane.
Regarding the control group, significant reductions of several
activities CAT, Px and GR, and level of GSH, as well as an
increase of LPx intensity and activity of GSHPx were observed
in animals treated with CCl4. Extracts, without a relevant
difference in their effects, succeeded in suppressing toxic CCl4
effects, protecting the liver from oxidative damage, and main-
taining levels of enzymatic and non-enzymatic antioxidants.
Results of investigation of S. montana extracts showed that
intoxication with CCl4 led to a significant decrease of hep-
atic DNA, with regard to the control group. Extracts (SME1
and SME2) entirely inhibited the decline of the amount of
hep. DNA. There were no notable differences between the
concentration of hep. DNA when SME1 and SME2 were ad-
ministered. Hydroxyproline, one of the parameters of liver
damage, was determined in liver tissue hydrolyzate of mice.
The groups treated with extracts (SME1 and SME2) did not
differ in the amount of hydroxyproline in comparison with
the control group, while it considerably increased under CCl4
treatment. According to obtained results, extracts applied
before a single CCl4 dose showed a positive effect, that is, a
significant decrease of hydroxyproline concentration towards
its concentration in the untreated group.
The increased levels of serum bilirubin, AST and ALT are
conventional indicators of liver injury (Thabrew et al., 1987).
The amount of serum bilirubin was not significantly different
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Table 2. Hepatoprotective influence of SC-CO2 (SME1) and spray-dried (SME2) extracts of winter savory (S. montana) on liver function
biochemical parameters.
Group Biochemical parameters
Hepatic DNAa Hydroxyprolin Bilirubin AST ALT
Control 6.222 ± 0.021 28.300 ± 0.141 0.118 ± 0.053 72.117 ± 0,496 20.667 ± 1.531
Control+CCl4 4.631 ± 0.015 a 91.533 ± 0.979 a 2.217 ± 0.306 a 590.667 ± 3,777 a 327.833 ± 15.250 a
SME1 6.248 ± 0.091 b 30.883 ± 0.483 b 0.113 ± 0.016 b 70.533 ± 2.925 b 19.633 ± 4.361 b
SME1+CCl4 6.413 ± 0.036 a,b 64.133 ± 7.156 a,b 1.028 ± 0.102 a,b 281.000 ± 19.910 a,b 106.667 ± 10.801 a,b
SME2 6.218 ± 0.015 b 29.267 ± 1.593 b 0.125 ± 0.019 b 67.000 ± 4,026 b 20.483 ± 3.596 b
SME2+CCl4 6.417 ± 0.089 a,b 62.650 ± 2.054 a,b 1.100 ± 0.126 a,b 219.000 ± 12.474 a,b 115.667 ± 12.832 a,b
a Values are expressed as mean ± standard deviation of six mice. Content of hepatic DNA is expressed in mg DNA/100 g liver. Contents of bilirubin, AST and
ALT are expressed in mg/dL, U/L and U/L, respectively. Concentration of hydroxyprolin is expressed in mg/100 mg of liver hydrolyzate. Letters a and b
denote statistically significant difference from the Control group and from the Control+CCl4 group based on post-hoc Bonferroni test at P<0.05 level.
from the control group when extracts were applied. After
CCl4 was applied, the amount of serum bilirubin was 18.8-
fold increased. Administration of SME1 and SME2 notably
decreased the concentration of serum bilirubin towards its
concentration in the untreated group. After exposure to CCl4,
serum AST and ALT were 8.2 and 15.9- fold increase, respec-
tively. Although both extracts notably reduced the negative
effect of CCl4 and significantly decreased serum AST activity,
SME2 was more efficient in reduction than SME1. Also, both
extracts considerably reduced the negative effect of CCl4 and
notably decreased serum ALT activity. Application of hepato-
toxic agents led to membrane damage and release of enzyme
from cytosol. In that context, reduction of levels of AST and
ALT by applied extracts indicates that stabilization of plasma
membrane and recovery of hepatic tissues damaged by CCl4
occurred. This effect is in compliance with the widespread
opinion that recovery of hepatic parenchyma and regeneration
of hepatocyte bring back the levels of transaminases within
physiological limits (Merlin and Parthasarathy, 2011; Thabrew
et al., 1987).
As it was previously described, the activity of the extracts in
the in vivo conditions was not significantly different although
their chemical profile was different. In our previous studies
(Vidovic´ et al., 2014; Vladic´ et al., 2016) the chemical composi-
tion of S. montana extracts obtained by SC-CO2 and essential
oil isolated from spray dried extract (SME2eo) was established.
In investigated SME2eo nine compounds were detected, which
was two-fold less than the number of compounds detected
in SME1. The most dominant component was phenolic com-
pound: carvacrol, with relative content of 78.61 and 71.82%,
in SME1 and SME2eo, respectively. In the sample obtained
by SC-CO2, p-cymene (3.96%) and trans-caryophyllene (2.4%)
were detected in a notably higher percentage in comparison
to SME2eo (0.36 and 0.24%), while caryophyllene oxide is
present in a higher percentage in SME2eo (1.31%) than SME1
(1.26%). Linalool was also detected in both samples as well
as terpinen 4-ol. The concentration of carvacrol in SME1 was
67-fold higher than in SME2eo. The content of carvacrol in
obtained SME1 was 60.82 g/100 g, while in SME2 it was 0.903
g/100 g (Vidovic´ et al., 2014; Vladic´ et al., 2016). Taking into ac-
count that the extract more abundant in carvacrol (SME1) did
not show dominant antioxidant influence in in vivo model, it
is possible to assume that both extracts activated the common
antioxidant mechanism. Also, it is possible that the synergistic
activity of all constituents was responsible for in vivo effect.
Apart from this, it was already established that some effects of
carvacrol can be improved by the presence of less dominant
components. For instance, in combination with carvacrol in
vitro, p-cymene is incorporated in the cytoplasmic membrane
and led to a more intensive transport of carvacrol through the
membrane (Ultee et al., 2002). Consequently, the antimicrobic
effect of carvacrol is improved with the presence of p-cymene.
Considering confirmed carvacrol potential in preserving the
physiological function of the liver, manifested hepatoprotec-
tive and antioxidant activities of S. montana extracts can be
at least partially subscribed to the presence of carvacrol. On
the contrary, examined extracts were obtained by different
extraction methods, and antioxidant activities of such extracts
as well as their carvacrol contents differed from one another.
For obtaining SM2 extract, a mixture of ethanol/water was
used as a solvent. Considering the polarity of this solvent,
the main compounds in extracts had a polar character and are
most likely responsible for antioxidant activity of SM2 in vivo.
Although both extracts showed high antioxidant activity in
vitro, SME2 exhibited 3-fold higher antioxidant activity than
SME1 (IC50 value of SME1: 17.40 µg/mL; IC50 value of SME2:
5.24 µg/mL (Vidovic´ et al., 2014). Due to a significantly low
share of carvacrol in SME2, it is highly likely that the antiox-
idant effect of SME2 is related to the high content of polar
polyphenols (content of total phenols 153.61 mg/g and total
flavonoids 118.69 mg/g (Vidovic´ et al., 2014). Abd El Tawab
et al. (2014) determined the presence of caffeic, syringic, and
rosmarinic acid in S. montana extract. Also, they identified gal-
lic, ferulic, cinnamic, and vanillic acids, and three flavonoids:
luteolin, rutin, and quercetin. In extracts obtained from non-
volatile fractions of S. montana, after hydrodistillation and
extraction by supercritical carbon dioxide, the presence of gal-
lic, caffeic, syringic, gentisic, ferulic, chlorogenic, coumaric,
and vanillic acids, epicatechin, and catechin (Silva et al., 2009).
Inhibition of free radicals is significant in terms of protection
of the damaged liver. DPPH radical is a stabile radical that is
known to remove labile hydrogen. Scavenging of free radicals
is one of the main antioxidant mechanisms which inhibits the
chain reaction of lipid peroxidation (Yang et al., 2010). The
results of DPPH assay indicate that S. montana extracts show
high scavenging effect towards free radicals. Moreover, this
can protect the liver from damage caused by the generated
free radical CCl3 induced by CCl4. Despite the fact that in
vitro results confirmed direct antioxidant activity of examined
extracts, it is not transparent whether this might also be the
case in vivo. In addition to in vitro antioxidant effect, a pos-
sible mechanism of S. montana extracts as hepatoprotective
agents are the reduction in activation of CCl4 into the reactive
form. Gutierrez and Navarro (2010) investigated antioxidant
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and hepatoprotective effects of the methanol extract of the
S. macrostema on CCl4- and paracetamol-induced damage in
rats. Authors assumed that S. macrostema extract elicits hep-
atoprotective effect through antioxidant activity (Gutierrez
and Navarro, 2010). Hepatoprotective activity of essential
oil of S. khuzestanica was evaluated. Within that study the
hepatoprotective activity of essential oil was confirmed, espe-
cially in combination with vitamin E. It also suggested that
potential reason for antioxidant and hepatoprotective effects
can be found in the high content of carvacrol (Assaei et al.,
2014). Looking at the significant effect the examined antiox-
idant enzymes, it can be inferred that SME1 and SME2 have
a potent hepatoprotective action through activation of com-
mon physiological defense mechanisms. Reported changes in
various enzyme activities may also indicate an indirect antiox-
idant effect due to the engagement of both CCl4 and extract
component(s). There is a demand for further investigation in
order to identify the active component(s) of extracts and their
biochemical mechanism responsible for the treatment of ox-
idative stress-induced liver damage as well as other disorders
caused by oxidative stress.
CONCLUSION
In this study, S. montana extracts inhibited hepatotoxicity in-
duced by CCl4, protected liver from oxidative damage, and
preserved the antioxidant level of protection. Both extracts
obtained by applying different technologies exhibited a pro-
tective effect without significant differences in their activities,
although a significant difference between the extracts and an-
tioxidant capacity in vitro was determined. Therefore, the most
probable mechanism of action of extracts is activation of phys-
iological defense mechanism and consequently the protective
activity. In addition, this finding indicates that the S. mon-
tana extracts produced by applying modern green technolo-
gies could be implemented in prevention and/or treatment of
acutely damaged liver. The next step in the research will be
the identification of active ingredients, investigation of mecha-
nisms of action, and evaluation of concentration-dependency
of extracts.
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